Bend Bioscience Industry Insights

  1. Risk Mitigation For Late-Stage Clinical Assets 6/11/2025

    Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.

  2. Bend Successfully Rescues Powder-Filled Capsule Program 5/16/2025

    Learn how to overcome tech transfer challenges and ensure consistent content uniformity by leveraging multidisciplinary expertise and decades of commercial encapsulation experience.

  3. Spray Dried Dispersions: Performance, Manufacturability, Stability 4/17/2025

    Explore advanced approaches to designing robust amorphous formulations and optimizing spray drying processes tailored specifically to difficult-to-formulate compounds.

  4. Transforming A Liquid Protein Solution Into A Solid Oral Dosage Form 3/4/2025

    Unlocking the potential of oral protein therapeutics requires innovative formulation and manufacturing strategies to overcome stability, absorption, and bioavailability challenges.

  5. Molecular Properties Of PROTACs And The Relationship To Formulation Design 3/4/2025

    Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.

  6. How To Choose The Right CDMO For Your Pharmaceutical Project- Part One: Will They Deliver? 4/17/2024

    Choosing the right CDMO is crucial for the success of your pharmaceutical project. Learn how to strike the ideal balance between an organization's technical expertise, facilities, and efficiency.

  7. Navigating OSD Formulation Development And Leveraging CDMO Partnership 4/17/2024

    Collaborating with an experienced CDMO can provide the expertise and facilities needed to navigate oral solid dose formulation complexities and ensure compliance with regulatory frameworks.

  8. Early Development Considerations For NCE Success: Quality Systems 3/1/2024

    Leveraging robust quality systems can improve efficiency throughout the product development lifecycle and help companies avoid unnecessary knowledge and tech transfer, saving both time and cost.

  9. Modified Release Formulations: Extending Drug Commercial Lifecycle 3/1/2024

    A CDMO with expertise in modified-release dosage forms can provide valuable assistance in formulation development, processing considerations, analytical challenges, and regulatory requirements.

  10. Early Development Considerations For Late-Stage NCE Success – Part Two 1/18/2024

    Discover how strategic partnerships, robust process development, and a keen awareness of supply chain vulnerabilities can pave the way to a successful clinical trial.